BMN 270

9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
Tue, 11/7/17 - 09:56 am
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
With ‘breakthrough’ status and a handy nickname, BioMarin plots speedy PhIII for gene therapy
Endpoints
Sun, 10/29/17 - 10:04 am
Biomarin
gene therapy
BMN 270
hemophilia A
BioMarin, Spark, raising the stakes for hemophilia
BioPharma Dive
Wed, 07/12/17 - 02:48 pm
Biomarin
Spark Therapeutics
hemophilia
BMN 270
SPK-9001
gene therapy
BioMarin announces 'encouraging' early-stage hemophilia therapy data
Marketwatch
Wed, 04/20/16 - 09:37 am
Biomarin
hemophilia
BMN 270